Jilin Provincial Tumor Hospital
27
1
4
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
3.7%
1 terminated/withdrawn out of 27 trials
75.0%
-11.5% vs industry average
33%
9 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (27)
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
Role: collaborator
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
Role: collaborator
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
Role: collaborator
RATME Vs LATME in Middle and Low Rectal Cancer
Role: collaborator
Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients
Role: collaborator
Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.
Role: collaborator
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Role: collaborator
Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)
Role: collaborator
Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC
Role: collaborator
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Role: collaborator
Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Role: collaborator
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
Role: collaborator
Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
Role: collaborator
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Role: collaborator
A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors
Role: collaborator
Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
Role: collaborator
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Role: collaborator
Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation
Role: collaborator
Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer
Role: collaborator